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http://dx.doi.org/10.1016/j.str.2014.10.008SUMMARY teins (Camps et al., 1990; Illenberger et al., 1997; IllenbergerPhospholipase C b (PLCb) enzymes are dramatically
activated by heterotrimeric G proteins. Central to this
response is the robust autoinhibition of PLCb by the
X-Y linker region within its catalytic core and by the
Ha20 helix in the C-terminal extension of the enzyme.
The molecular mechanism of each and their mutual
dependence are poorly understood. Herein, it is
shown that distinct regions within the X-Y linker
have specific roles in regulating activity. Most impor-
tant, an acidic stretch within the linker stabilizes a lid
that occludes the active site, consistent with crystal
structures of variants lacking this region. Inhibition
by the Ha20 helix is independent of the X-Y linker
and likely regulates activity by limiting membrane
interaction of the catalytic core. Full activation of
PLCb thus requires multiple independent molecular
events induced by membrane association of the cat-
alytic core and by the binding of regulatory proteins.
INTRODUCTION
Phospholipase C (PLC) enzymes hydrolyze the inner membrane
lipid phosphatidylinositol-4,5-bisphosphate (PIP2) to produce
inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) in
response to diverse cellular stimuli. IP3 promotes the release
of intracellular Ca2+, and DAG, together with increased Ca2+, ac-
tivates protein kinase C (PKC) (Gresset et al., 2012; Kadamur and
Ross, 2013). Thus, PLCb enzymes contribute to numerous pro-
cesses, including chemotaxis (Li et al., 2000; Tang et al., 2011),
neurological function (Han et al., 2006; Kim et al., 1997), and
opioid sensitivity (Bianchi et al., 2009; Bonacci et al., 2006;
Mathewset al., 2008). Thephysiological role ofPLCb is best char-
acterized in the cardiovascular system, where dysregulation of
activation or expression can result in hypertrophy (Filtz et al.,
2009; Grubb et al., 2012) and heart failure (Mende et al., 1998;
Woodcock et al., 2010). Pathways for PLCb activation involve
direct interactions with the heterotrimeric G protein subunits
Gaq and Gbg (Camps et al., 1992a, 1992b; Jiang et al., 1994;
Paterson et al., 1995; Smrcka et al., 1991; Smrcka andSternweis,
1993) and with the Rac family of small-molecular-weight G pro-1844 Structure 22, 1844–1854, December 2, 2014 ª2014 Elsevier Ltdet al., 2003a). These interactions increase the rate of PIP2 hydro-
lysis up to 60-fold.
PLCb enzymes are composed of an N-terminal pleckstrin ho-
mology (PH) domain, four tandem EF hand repeats, a catalytic
TIM barrel domain (split by an inhibitory X-Y linker), a C2 domain,
and an 400-amino-acid extension (Gresset et al., 2012), which
is unique to the PLCb family. Its amino terminus contains the
proximal C-terminal domain (CTD), which houses the primary
Gaq binding site (the Ha1/Ha2 helical elbow) (Waldo et al.,
2010) and the Ha20 autoinhibitory helix (Lyon et al., 2011). An un-
conserved CTD linker connects the proximal and distal CTDs,
the latter of which forms an extended coiled-coil domain that
contributes to Gaq binding and serves as the primary mem-
brane-binding determinant of the enzyme (Ilkaeva et al., 2002;
Jenco et al., 1997; Kim et al., 1996; Lyon et al., 2013; Park
et al., 1993; Singer et al., 2002) (Figure 1A). Both Rac and Gbg
are thought to activate PLCb via direct interaction with the cata-
lytic core (Guo et al., 2003; Illenberger et al., 2003a; Jezyk et al.,
2006; Runnels and Scarlata, 1999; Sankaran et al., 1998), which
is thought help orient the catalytic core of the enzyme with
respect to the membrane where its substrate is found (Drin
et al., 2006; Han et al., 2011; Illenberger et al., 2003b).
Two autoinhibitory elements have been identified in PLCb: the
X-Y linker within the TIM barrel domain (Hicks et al., 2008) and
the Ha20 helix in the C-terminal extension (Lyon et al., 2011) (Fig-
ures 1B and 1C). The X-Y linker varies in sequence and length
among PLCb isoforms but can be subdivided into an uncon-
served N-terminal region, a highly acidic stretch of 10–15 resi-
dues, and a conserved C-terminal region of15 residues that oc-
cludes the active site in all PLCb crystal structures determined to
date (Hicks et al., 2008; Jezyk et al., 2006; Lyonet al., 2013;Waldo
et al., 2010) (Figure S1 available online). Deletion or cleavage of
the X-Y linker increases basal activity in PLCb and other PLC pro-
teins, consistent with a commonmode of autoinhibition within the
PLC family (Hicks et al., 2008; Schnabel and Camps, 1998; Zhang
and Neer, 2001). Displacement of the ordered part of the linker
has been proposed to occur via electrostatic repulsion between
the acidic stretch of the linker and the negatively charged inner
leaflet of the membrane in a form of interfacial activation (Hicks
et al., 2008; Waldo et al., 2010).
The Ha20 helix binds to a highly conserved cleft between
the TIM barrel and C2 domains of the catalytic core, in close
proximity to the active site and the ordered region of the X-YAll rights reserved
Figure 1. The PLCb X-Y Linker and Proximal CTD Are Highly Conserved Elements that Regulate Basal Activity
(A) Primary structure. Numbers above the diagram correspond to domain boundaries. In the sequence alignment human PLCb1 (AAF86613), PLCb2
(NP_004564), and PLCb3 (NP_000923), residues in the acidic stretch are shown in red, and the C-terminal ends of X-Y linker internal deletions in PLCb3 are noted
below. The primary Gaq binding site in the proximal CTD is shown in blue.
(B) Crystal structure of the Gaq-PLCb3-D892Dacid complex. AlF4
-activated Gaq is shown as a gray surface, and the domains of PLCb3 are colored as in (A). The
observed N- and C-termini of PLCb3-D892Dacid and Gaq are labeled N and C, and N
0 and C0, respectively. Dashed lines correspond to disordered loops.
(C) View of the PLCb3 catalytic core (PDB entry 3OHM) and proximal CTD from the perspective of the membrane plane. PLCb3 is colored as in (A). Circled minus
signs indicate the relative position of the acidic stretch in the X-Y linker.
See also Figures S1 and S2.
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X-Y linker only by the Ta5 helix of the TIM barrel domain, an
element implicated in Gbg-mediated activation (Bonacci et al.,
2005; Kuang et al., 1996; Sankaran et al., 1998). Mutations
within the catalytic core-Ha20 interface decrease the melting
point of the enzyme as measured by differential scanning
fluorimetry (DSF), increase basal activity, and decrease the
efficacy of Gaq activation, whose binding is proposed to
displace Ha20 from the catalytic core (Lyon et al., 2011). Thus,
there are several possible models for the molecular basis under-
lying autoinhibition by Ha20. One is for Ha20 to dampen the
overall dynamics of the catalytic core, inhibiting displacement
of the X-Y linker. Another is for residues in the proximal CTD pre-
ceding Ha20, including those that bind Gaq, to interact with and
stabilize the X-Y linker in the absence of Gaq. Still another is for
Ha20 to act independently of the X-Y linker, such as by prevent-
ing the catalytic core from interacting productively with the
membrane.
Herein, protease protection and activity assays, DSF, and X-
ray crystallography were used to determine how distinct regions
within the X-Y linker and the proximal CTD contribute to autoin-Structure 22, 1844–18hibition of PLCb and whether they act independently of each
other. The ability of these regions to influence activation by het-
erotrimeric G proteins was also assessed. Deletion of the acidic
stretch within the X-Y linker decreases thermal stability of the
enzyme, increases basal activity, and decreases activation by
heterotrimeric G proteins. Consistent with these observations,
crystal structures of PLCb3 lacking the acidic stretch, yet still re-
taining the C-terminal region of the X-Y linker, exhibit an open
active site, allowing cocrystallization with IP3. In contrast, the
Ha20 helix dampens basal activity via a mechanism independent
of the X-Y linker and serves to prevent full activity until Gaq is
bound. This finding could help explain the basis for synergistic
activation of the enzyme by Gaq and Gbg (Philip et al., 2010; Re-
bres et al., 2011).
RESULTS
Ha20 Docking Does Not Alter X-Y Linker Proteolysis
Ha20 may regulate PLCb activity and facilitate displacement of
the X-Y linker by modulating the conformational dynamics of
the catalytic core. Disruption of the interactions between Ha2054, December 2, 2014 ª2014 Elsevier Ltd All rights reserved 1845
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Regulation of Phospholipase Cband the catalytic core significantly decreases the melting
point (Tm) of PLCb3 (Lyon et al., 2011). Therefore, the proteolytic
sensitivity of two human PLCb3 C-terminal truncations was
compared: PLCb3-D847, which corresponds to the catalytic
core, and PLCb3-D892, which contains the catalytic core and
the proximal CTD, including Ha20. PLCb3-D847 and PLCb3-
D892 were incubated with trypsin or clostripain and analyzed
by SDS-PAGE (Figure S2). The individual bands and the total
proteolytic reactions were analyzed by MALDI-TOF and tandem
mass spectrometry (MS/MS) to determine themolecular weights
and sequences of the proteolytic fragments (Table S1). MS/MS
analysis showed that PLCb3-D847 and PLCb3-D892 have the
same major cleavage sites after residues Arg483 and Arg545.
These positions are within the disordered N-terminal region of
the X-Y linker, with Arg545 immediately preceding the acidic
stretch. Therefore, the presence of Ha20 seems to have no effect
on the susceptibility of cleavage sites in PLCb3. The acidic
stretch, the C-terminal ordered region of the X-Y linker, and
proximal CTD contain predicted trypsin and clostripain sites.
However, no significant proteolysis was detected within these
regions. These results are consistent with Ha20 and, unexpect-
edly, the acidic stretch being stably bound to the catalytic core
in solution.
The X-Y Linker and Ha20 Regulate Basal Activity
Independently
To examine the dependence of autoinhibition by the X-Y linker
on Ha20, internal deletions were created within the X-Y linker in
the background of both PLCb3-D847 and PLCb3-D892, and
their basal activities were compared. Deletions were designed
considering the published crystal structures of PLCb (Hicks
et al., 2008; Jezyk et al., 2006; Lyon et al., 2011, 2013; Waldo
et al., 2010) and the observed protease cleavage sites
(Table S1). Homology modeling of the resulting variants (Roy
et al., 2010; Zhang, 2008) indicated that these changes were
unlikely to perturb the structure of the catalytic core. The
D471–559 deletion (denoted as Ddisorder) removes the uncon-
served and disordered N-terminal region of the X-Y linker.
D471–569 (denoted as Dacid) removes both the N-terminal re-
gion and the acidic stretch. D471–581 (denoted as Dall) re-
moves the entire X-Y linker, leaving only enough residues to
form a stable loop between the Tb4 strand and Ta4 helix.
With the exception of PLCb3-D847Dacid, which did not express,
all variants were purified to homogeneity. To test whether the
disordered loop linking the C terminus of the catalytic core
and Ha20 plays a role in autoinhibition, the D859–863 deletion
(denoted as DLINPI) was created in the background of
PLCb3-D892. This removes the Gaq binding site and consider-
ably shortens the loop.
PLCb3-D847Ddisorder exhibited 10-fold lower basal activity
relative to PLCb3-D847 (2.6 ± 0.5 versus 30.0 ± 3.5 nmol IP3/
min/nmol PLCb3-D847, respectively). In contrast, PLCb3-
D847Dall was activated 30-fold relative to PLCb3-D847 (980 ±
92 nmol IP3/min/nmol, p% 0.0001) (Figure 2A; Table 1). Similar
trends were observed in the background of PLCb3-D892
(i.e., in the presence of bound Ha20). PLCb3-D892Ddisorder had
4-fold reduced basal activity relative to PLCb3-D892 (0.6 ±
0.09 nmol IP3/min/nmol PLCb3 variant), whereas PLCb3-
D892Dall had 100-fold higher activity (250 ± 37 nmol IP3/min/1846 Structure 22, 1844–1854, December 2, 2014 ª2014 Elsevier Ltdnmol PLCb3 variant). PLCb3-D892Dacid, which lacks the acidic
stretch but retains the ordered C-terminal region, had even
higher activity (320 ± 26 nmol IP3/min/nmol PLCb3-D892Dacid,
p % 0.0001 compared to PLCb3-D892). PLCb3-D892DLINPI
exhibited no defect in basal activity. Altogether, these data pro-
vided two surprising results. The first is that deletion of the N-ter-
minal region in the X-Y linker leads to loss of activity, suggesting
that the length of the linker plays a role in autoinhibition. The sec-
ond is that removal of the N-terminal region and acidic stretch
(Dacid) has greater activity than removal of the entire X-Y linker
(Dall). Independently of the X-Y linker deletions, Ha2
0 repressed
basal activity, as each PLCb3-D892 variant had lower specific
activity than its PLCb3-D847 counterpart.
The X-Y Linker Regulates Access to the Active Site
The X-Y linker and Ha20 may both regulate access of ligands
to the active site. To test whether deletion of Ha20 or of regions
within the X-Y linker facilitate ligand binding in solution, DSF
was used to detect the direct binding of IP3. The Tm values
of PLCb3-D892, PLCb3-D847, and the most active linker dele-
tion variants (PLCb3-D892Dacid, PLCb3-D892Dall, and PLCb3-
D847Dall) were determined in the presence or absence of 5 mM
IP3. PLCb3-D847 and PLCb3-D892 did not show any significant
change in thermal stability in response to IP3, consistent with
their active sites being blocked, impairing ligand binding (Fig-
ure 2B; Figure S3A). However, the Tm of PLCb3-D847Dall was
significantly increased by 2.5C in the presence of IP3 and by
3C for PLCb3-D892Dacid and PLCb3-D892Dall (Figure 2B; Table
S2). These results are consistent with the idea that deletions
including the acidic stretch facilitate ligand binding in the
active site. The presence of Ha20 seems to have little effect on
substrate access because similar DTm values were observed
for PLCb3-D892Dall versus PLCb3-D847Dall, and PLCb3-D847
versus PLCb3-D892.
Deletion of the Acidic Stretch within the X-Y Linker
Decreases Thermal Stability
Based on the aforementioned results, PLCb3 variants lacking the
acidic stretch or the entire X-Y linker have significantly increased
basal activity and are able to bind IP3, potentially due to loss of
the active site blockade. DSF was used to determine whether
deletions within the X-Y linker alter the Tm values of the apo en-
zymes. PLCb3-D847 and PLCb3-D847Ddisorder exhibited similar
Tm values, consistent with deletion of a disordered region. The
Tm of PLCb3-D847Dall, however, was decreased relative to
PLCb3-D847 by 4C (p% 0.0001) (Figure 2C; Table S3), poten-
tially reflecting a loss of stabilizing interactions between the cat-
alytic core and the acidic stretch and/or the C-terminal region of
the X-Y linker.
PLCb3-D892 had a Tm 6
C higher than that of PLCb3-D847
due to the presence of Ha20, consistent with prior reports
(Lyon et al., 2011), and the Tm of PLCb3-D892Ddisorder was
similar. However, PLCb3-D892Dacid and PLCb3-D892Dall both
had significantly decreased Tm values (3C and 4C, respec-
tively), suggesting that the acidic stretch is primarily responsible
for the destabilization observed in the PLCb3-D847 and PLCb3-
D892 variants. The most likely explanation would be via direct
interactions with the catalytic core. PLCb3-D892DLINPI exhibited
no change in thermal stability relative to PLCb3-D892.All rights reserved
Figure 2. Basal Activity and DSF Measurements of PLCb3 Variants
(A) Deletions within the X-Y linker, but not the Gaq binding site, alter basal
activity. Increased activity is observed when the acidic stretch or entire
linker is removed. Data represent at least five experiments performed in
duplicate ± SEM.
(B) Addition of 5 mM IP3 to hyperactive PLCb3 variants increases their thermal
stability. Tm values were determined by monitoring the increase in fluores-
cence of ANS as a function of temperature. Data represent at least five ex-
periments performed in triplicate ± SEM.
Table 1. Basal Activity of PLCb3 Variants
Variant
Basal Specific Activity ±
SEM (nmol IP3/min/nmol
PLCb3) (n)
Fold Increase Relative
to PLCb3-D847 or
PLCb3-D892
PLCb3-D847 30 ± 3.5 (9) 1
-Ddisorder 2.6 ± 0.5 (7) 0.08
-Dall 980 ± 91 (10) 33
PLCb3-D892 2.3 ± 0.3 (9) 1
-Ddisorder 0.6 ± 0.09 (7) 0.3
-Dacid 320 ± 26 (5) 140
-Dall 250 ± 37 (10) 110
-DLINPI 2.0 ± 0.4 (5) 0.9
Data represent five to ten individual experiments measured in duplicate ±
SEM, from at least two purifications.
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Structure 22, 1844–18Deletion of the X-Y Linker Diminishes Fold Activation by
Heterotrimeric G Proteins
Activation of PLCb3 by Gaq and Gbg are hypothesized to involve
interfacial activation (Hicks et al., 2008; Waldo et al., 2010), and
Ha20 displacement is proposed to be an additional step in activa-
tion by Gaq (Lyon et al., 2011). Little is known regarding the
mechanisms of activation by Gbg, although it does not require
the proximal and distal CTDs (Bonacci et al., 2005; Jenco
et al., 1997; Kuang et al., 1996; Lee et al., 1993). To identify the
roles of specific regions within the X-Y linker and the proximal
CTD in activation by heterotrimeric G proteins, we used lipo-
some-based activity assays to measure Gaq and Gbg activation
of the PLCb3-D847 and PLCb3-D892 variants.
Gaq can only activate the PLCb3-D892 variants because they
retain the proximal CTD (Waldo et al., 2010). PLCb3-D892 was
activated 17-fold by the addition of Gaq to 40 ± 3.9 nmol IP3/
min/nmol PLCb3 (Lyon et al., 2011, 2013) (Figure 3A; Table 2),
and loss of the Gaq binding site in PLCb3-D892DLINPI completely
eliminated activation. PLCb3-D892Ddisorder, PLCb3-D892Dacid,
and PLCb3-D892Dall were all activated by Gaq but with varying
efficacies (Figure S3B; Table 2). PLCb3-D892Ddisorder was acti-
vated 60-fold by Gaq to a maximum specific activity of 37 ±
3.9 nmol IP3/min/nmol PLCb3 variant. In contrast, Gaq addition
only increased activity by 3- to 4-fold for PLCb3-D892Dacid
and PLCb3-D892Dall to 1,000 nmol IP3/min/nmol PLCb3. The
differences in efficacy cannot be attributed to defects in binding,
as there were no significant differences in half maximal effective
concentration (EC50) values (Table 2). Instead, changes in
efficacy were due to differences in basal activities. PLCb3-
D892Dacid and PLCb3-D892Dall both exhibited 30-fold higher
maximal Gaq-stimulated activity than PLCb3-D892 and PLCb3-
D892Ddisorder, again demonstrating a prominent role of the acidic
stretch in autoinhibition.(C) Deletions including the acidic stretch show decreased thermal stability
compared to variants containing intact X-Y linkers. The Tm of each PLCb3
variant was determined with respect to PLCb3-D847, used as a control on
each plate. PLCb3-D892 and its variants have higher thermal stability relative
to PLCb3-D847 variants due to Ha20. Data represent at least four experiments
performed in triplicate ± SEM.
In (B) and (C), *p% 0.5, **p% 0.01, ***p% 0.001, ****p% 0.0001.
See also Figure S3A and Tables S2 and S3.
54, December 2, 2014 ª2014 Elsevier Ltd All rights reserved 1847
Figure 3. Heterotrimeric G Protein Activation of PLCb3 Variants
The activity of PLCb3 variants was measured at 30C for 5 min at increasing
concentrations of AlF4
-activated Gaq or Gb1g2.
(A) Gaq activates PLCb3-D892 3- to 60-fold. As expected, loss of the pri-
mary Gaq binding site (PLCb3-D892DLINPI) abolishes Gaq activation.
PLCb3-D892Ddisorder has the lowest basal activity and thus shows the
greatest fold increase, whereas PLCb3-D892Dacid and PLCb3-D892Dall
variants are weakly activated. Data represent at least five experiments in
duplicate ± SEM.
(B) Gb1g2-mediated activation of PLCb3 variants. Gb1g2 robustly activates
PLCb3Ddisorder variants due to their low basal activity, whereas PLCb3Dacid and
PLCb3Dall variants are activated only 3- to 5-fold. Deletion of the Gaq binding
site in PLCb3-D892DLINPI had no effect on Gb1g2 activation. Data represent at
least four experiments performed in duplicate ± SEM.
See also Figures S3B–S3D and Table 2.
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Regulation of Phospholipase CbPLCb3-D892 and its variants were all activated by Gb1g2 with
trends similar to those observed with Gaq (Figures S3C and
S3D), with the exception of PLCb3-D892DLINPI, which was com-
parable to PLCb3-D892 (Figure 3B; Table 2). PLCb3-D892 was
activated 25-fold by Gb1g2, to a maximum specific activity of
56 ± 2.2 nmol IP3/min/nmol PLCb3 variant. PLCb3-D892Ddisorder
was activated 56-fold, whereas PLCb3-D892Dacid and PLCb3-
D892Dall were only activated 3- and 4-fold, respectively, to
1,000 nmol IP3/min/nmol PLCb3 variant. PLCb3-D847 was
activated 4-fold, due to loss of autoinhibition by Ha20.
PLCb3-D847Ddisorder was activated 19-fold to 57 ± 3.1, and1848 Structure 22, 1844–1854, December 2, 2014 ª2014 Elsevier LtdPLCb3-D847Dall was activated 5-fold to 4,900 ± 250 nmol
IP3/min/nmol PLCb3 variant. As in the case for Gaq, the EC50
values for Gb1g2 activation were comparable between variants
(Table 2). Strikingly, PLCb3-D847 variants have significantly
higher Gb1g2-dependent maximum specific activities compared
to their PLCb3-D892 counterparts, again demonstrating that
Ha20 is a potent inhibitor of PLCb3 activity, even under saturating
concentrations of Gb1g2.
Deletion of the Acidic Stretch of the X-Y Linker
Disorders the Active Site Lid
To determine the structural basis by which loss of the acidic
stretch increases activity and substrate access, crystal struc-
tures were determined of Gaq–PLCb3-D892Dacid and of IP3 in
complex with Gaq–PLCb3-D892Dacid and Gaq–PLCb3-D892Dall
(Table 3). Gaq was included to facilitate crystallization, but
because Ha20 is bound to the catalytic core via in trans crystal
contacts in these structures (Lyon et al., 2013; Waldo et al.,
2010), they are thought to represent the basal state of each
PLCb3-D892 variant. The Gaq–PLCb3-D892Dacid (Figure 1B)
and Gaq–PLCb3-D892Dall structures are very similar to that of
Gaq–PLCb3-D882 (root-mean-square deviation [rmsd] = 0.4 A˚
2
for observed Ca atoms) (Figure 4A). The largest conformational
differences occur at the C terminus of Ha20 and in some loops
of the PH domain, likely due to slight differences in crystal
packing. Thus, deletions within the X-Y linker do not perturb
the overall structure of the complex.
In all previously reported PLCb structures, part of the ordered
C-terminal region of the X-Y linker (generally human PLCb3 res-
idues 575–584) folds into a short 310 helix (the lid helix) that oc-
cludes the active site (Hicks et al., 2008) (Figure S1). Based on
the structure of IP3 and analogs bound in the active site of
PLCd (Essen et al., 1996, 1997), this helix would prevent sub-
strate binding. However, in the Gaq–PLCb3-D892Dacid structure,
only residues 582–584 are observed (Figure 4B). The best expla-
nation is that deletion of the acidic stretch eliminates docking of
the lid helix, because modeling indicates that there is a sufficient
number of residues in the remaining X-Y linker to fully form the lid
helix structure.
Because the Tm values of PLCb3-D892Dacid and PLCb3-
D892Dall were increased by IP3, these variants were cocrystal-
lized with IP3. In the resulting structures, strong density for IP3
was observed in their active sites, permitting modeling of the
ligand (Figures 4C and 4D; Table 3). These structures confirm
that PLCb and PLCd, and likely all PLC enzymes, recognize the
PIP2 substrate in a similar way (Gresset et al., 2012). As in
PLCd (Essen et al., 1996, 1997), conserved basic residues in
the active site recognize the phosphate groups of IP3, with the
1- and 4-phosphates forming the majority of contacts. IP3 binds
in the active site such that its 1-phosphate and 2-hydroxyl coor-
dinate the catalytic Ca2+ atom, although in a slightly different
orientation than PLCd (Figure S4A). PLCb3-Ser619 and Arg646
form hydrogen bonds with the 4-phosphate and the 3-hydroxyl
groups of IP3, respectively, and Tyr648 stacks with the inositol
ring (Figure S4B). Based on the PLCd-IP3 structure, additional
contacts are likely mediated by water molecules that are not
observed due to lower resolution. In these structures, interpret-
able electron density for the linker is not observed until residue
589, even though PLCb3-D892Dacid contains linker residuesAll rights reserved
Table 2. Heterotrimeric G Protein Activation of PLCb3 Variants
Variant
Gaq-Dependent
Maximum Specific
Activity (nmol IP3 min
1
nmol PLCb31) (n)
Maximum Fold
Increase in Activity
over Basal Gaq EC50 (nM)
Gbg-Dependent
Maximum Specific
Activity (nmol IP3 min
1
nmol PLCb31) (n)
Maximum Fold
Increase in Activity
over Basal Gbg EC50 (nM)
PLCb3-D892 40 ± 4 (11) 17 700 ± 115 56 ± 2 (10) 24 102 ± 23
-Ddisorder 37 ± 4 (10) 63 2,180 ± 650 39 ± 1 (11) 56 54 ± 10
-Dacid 1,050 ± 43 (5) 3 155 ± 21 1,110 ± 28 (6) 3 25 ± 3
-Dall 1,070 ± 29 (5) 4 78 ± 17 970 ± 48 (5) 4 15 ± 5
-DLINPI ND ND ND 55 ± 4 (4) 28 66 ± 8
PLCb3-D847 ND ND ND 114 ± 6 (5) 4 8 ± 3
-Ddisorder ND ND ND 56 ± 4 (5) 22 330 ± 6
-Dall ND ND ND 4,900 ± 250 (9) 5 140 ± 30
Data represent individual experiments measured in duplicateto ± SEM from at least two purifications. ND, not determined.
Structure
Regulation of Phospholipase Cbstarting at 569 and PLCb3-D892Dall at 582. The fact that these
structures are technically ‘‘Ha20 bound’’ reinforces the conclu-
sion from the DSF experiments (Table S2) that Ha20 does not
control ligand accessibility of the active site.Table 3. Data Collection and Refinement Statistics
Statistic
Gaq–PLCb3-
D892Dacid
Gaq–PLCb3-
D892Dacid $IP3
Gaq–PLCb3-
D892Dall$IP3
Data Collection
Space group C121 C121 C121
Cell dimensions
a, b, c (A˚) 200.6, 88.8,
92.2
201.9, 89.2,
92.6
205.9, 89.9,
93.3
a, b, g () 90, 101, 90 90, 102, 90 90, 102, 90
Resolution (A˚) 30.0–3.00
(3.05–3.00)a
29.4–3.28
(3.34–3.30)a
30.0–3.40
(3.46–3.40)a
Rsym or Rmerge 0.100
(0.527)
0.221
(0.480)
0.142
(0.444)
I/sI 14.3 (1.8) 9.52 (3.3) 7.7 (2.1)
Completeness (%) 99.8 (97.2) 85.6 (64.6) 96.1 (95.9)
Redundancy 5.1 (3.9) 3.7 (2.7) 3.3 (2.1)
Refinement
Resolution (A˚) 30.0–3.0 29.4–3.30 30.0–3.40
No. of reflections 31,965 21,289 22,003
Rwork/Rfree 0.195/0.240 0.208/0.267 0.212/0.277
No. of atoms
Protein 8,684 8,646 8,621
Ligand/ion 63 71 61
B-factors
Protein 59.57 73.74 85.73
Ligand/ion 32.65 68.45 86.23
rmsds
Bond
lengths (A˚)
0.004 0.005 0.005
Bond
angles ()
0.887 0.930 1.016
Data sets from two regions of a single crystal were merged for the Gaq–
PLCb3-D892Dacid structure.
aValues in parentheses are for highest resolution shell.
Structure 22, 1844–18DISCUSSION
Under normal cellular conditions, PLCb activity is very low,
and direct interactions with Gaq, Gbg, or Rac proteins dra-
matically enhance the rate of PIP2 hydrolysis (Lyon and
Tesmer, 2013). The low basal activity of PLCb enzymes has
thus far been attributed to two structural elements: the X-Y
linker of the TIM barrel domain and the Ha20 helix of the
proximal CTD, as perturbation of either element increases
basal activity. The results herein reconfirm that these elements
are essential for maintaining the basal activity of PLCb and
demonstrate that they inhibit activity through independent
mechanisms. The presence of Ha20 decreases maximal
activity of PLCb3-D892 under every condition. Protease pro-
tection assays indicate that Ha20 does not alter the susceptibil-
ity of the enzyme to proteolysis, even within the X-Y linker, a
known proteolytically sensitive site (Figure S2; Table S1)
(Schnabel and Camps, 1998). Furthermore, this assay showed
that the proximal CTD and the region of the X-Y linker span-
ning the acidic stretch to its C terminus are both protected
from proteolysis in solution, even though these regions contain
protease consensus sites and exhibit conformational flexibility
in crystal structures. Such protection is likely conferred via
interactions of these or adjacent regions with the catalytic
core, consistent with the observation that deletion of the acidic
stretch of the X-Y linker decreases the Tm of the catalytic core
(Figure 2C; Table S3). It was also hypothesized that the dis-
ordered region preceding Ha20 in the proximal CTD, which
would be topologically constrained due to interactions of
Ha20 with the catalytic core, could contribute to regulation
of basal activity through interactions with the X-Y linker.
The most likely and conserved element to mediate such an
interaction would be the LINPI motif, which forms the primary
Gaq binding site (Waldo et al., 2010). The DLINPI deletion,
however, had no effect in any assay except Gaq activation
(Figure 3A; Figure S3B; Table 2). Truncating the loop by five
amino acids via this deletion also has no effect. Thus, re-
gulation of basal activity by the proximal CTD seems to
depend entirely on the interaction of Ha20 with the catalytic
core. We hypothesize that this interaction somehow prevents
the active site from achieving optimal interactions with lipid
bilayers.54, December 2, 2014 ª2014 Elsevier Ltd All rights reserved 1849
Figure 4. Structural Characterization of
PLCb3 Variants
PLCb3 variants are colored as in Figure 1A, and the
observed ends of the X-Y linker are marked with
pink asterisks. The Ha20 helix is shown in cyan.
(A) Active site of the Gaq-PLCb3-D882 complex
(PDB entry 3OHM). Residues Leu341, Phe381,
Met383, and Val654 form the hydrophobic ridge,
which anchors the active site at the membrane for
catalysis (Essen et al., 1997; Lyon and Tesmer,
2013). The lid helix at the C-terminal end of the X-Y
linker physically occludes the active site.
(B) The active site of the Gaq-PLCb3-D892Dacid
complex is open. Residues that would form the lid
helix are present in this variant, but deletion of the
acidic stretch leads to their disorder.
(C) Active site of the Gaq-PLCb3-D892Dacid$IP3
complex. Electron density is observed for most
atoms of the ligand, as seen in a 3s jFoj  jFcj omit
map (green wire cage). Electron density for the X-Y
linker is not observed until residue 589.
(D) Active site of the Gaq-PLCb3-D892Dall$IP3
complex. Strong 3s jFoj j Fcj omit map density is
observed for the entire IP3 molecule. Deletion of
the entire X-Y linker in this variant has no effect on
the position of the bound ligand.
See also Figure S4.
Structure
Regulation of Phospholipase CbThe X-Y linker varies in length among PLCb isoforms, but all
have an unconserved N-terminal region and two conserved ele-
ments: an acidic stretch and a C-terminal region that forms the
active site lid helix. These studies demonstrate specific and, in
some cases, unanticipated roles for each of these elements
(Hicks et al., 2008). Deletion of the N-terminal region decreased
basal activity (Figure 2A; Table 1), possibly due to decreased
conformational flexibility, which may hinder ejection of the lid he-
lix when the catalytic core approaches the membrane. In
contrast, any deletion including the acidic stretch dramatically
increased basal activity, decreased the Tm, and facilitated IP3
binding (Figure 2; Table 1; Table S2). These results are consistent
with the acidic region regulating access to the active site. Similar
trends were reported for deletions within the X-Y linker of human
PLCb2 (Hicks et al., 2008): deletions within PLCb2 encompass-
ing the majority of the acidic stretch or the entire X-Y linker (hu-
man PLCb2 residues 470–515 and 470–524, respectively) had
increased basal activity compared to wild-type. In this same
study, deletion of just the ordered portion of the X-Y linker (res-
idues 516–535) also elevated basal activity but not to the same
extent as deletions including the acidic stretch. All of these re-
sults support a model wherein the acidic stretch somehowmain-
tains the structural integrity of the lid helix, which is insufficient to
inhibit basal activity on its own.
Maximal Gaq or Gbg-stimulated activity requires the release of
autoinhibition mediated by the X-Y linker and Ha20. Deletion of
the acidic stretch or entire X-Y linker in PLCb3 decreased the ef-
ficacy of G protein activation, whether Ha20 was present or not
(Figure 3; Table 2), just as deletion of the acidic stretch or the
entire X-Y linker in PLCb2 decreased fold activation by heterotri-
meric Gproteins and Rac1 (Hicks et al., 2008). Interestingly, even1850 Structure 22, 1844–1854, December 2, 2014 ª2014 Elsevier Ltdthough Gbg is not believed to interact with or displace Ha20, it
promoted maximal PLCb3-D892 activity that was comparable
to that of Gaq (Figure 3; Table 2). Thus, interfacial activation by
Gaq in the context of this assay system may simply be less effi-
cient than that by Gbg, possibly reflecting that heterogeneously
palmitoylated Gaq (Lyon et al., 2013) or the distal CTD, which
also interacts with Gaq, was absent in the variants tested in
this study (Kim et al., 1996; Lee et al., 1993; Wu et al., 1993; Il-
kaeva et al., 2002; Lyon et al., 2013; Singer et al., 2002). In every
case, Ha20 acted as a brake on Gbg activation, because none of
the PLCb3-D892 variants reached the same maximum specific
activity exhibited by PLCb3-D847Dall, which lacks all known
autoinhibitory elements.
Thus, Ha20 dampens both basal and G-protein-stimulated ac-
tivity independently of the X-Y linker and may underlie the syner-
gistic activation of PLCb3 by Gaq and Gbg subunits (Philip et al.,
2010; Rebres et al., 2011). The residual 3- to 4-fold activation
mediated by Gaq in the context of PLCb3-D892Dall could reflect
displacement of the Ha20 helix. However, it is not entirely clear
what is responsible for the residual 3- to 4-fold activation
induced by Gbg in the context of PLCb3-D847Dall, which has
no known autoinhibitory elements remaining. This may be
due to membrane-induced conformational changes within the
PLCb active site. Alternatively, it may reflect a shift in equilibrium
between soluble andmembrane-bound enzyme or the existence
of other yet-to-be-determined inhibitory elements.
Prior work hypothesized that the acidic stretch of the X-Y linker
serves to drive repulsive interactions with the membrane, eject-
ing the lid helix from the active site (Hicks et al., 2008). The
studies presented here are instead consistent with a mechanism
wherein the acidic stretch acts as a clasp to stabilize the lid helixAll rights reserved
Figure 5. A Model of PLCb Autoinhibition by the X-Y Linker
Under basal conditions, the lid helix at the C-terminal end of the X-Y linker
blocks access to the active site. The acidic stretch interacts with conserved
solvent-exposed basic residues on one face of the TIM barrel domain. In this
model, based on PDB entry 2FJU, the last two residues of the PLCb2 acidic
stretch, Glu512 and Glu513, interact with conserved lysines and arginines.
Breaking the electrostatic interactions between the TIM barrel domain and the
acidic stretch, such as by interactions with the cell membrane, leads to loss of
structure in the lid helix, increasing activity. Meanwhile, the Ha20 helix remains
bound to the catalytic core, acting as a brake on PLCb activity via an inde-
pendent mechanism until displaced by the binding of Gaq.
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Regulation of Phospholipase Cbby interacting with highly conserved basic residues in close
proximity to the active site. Evidence for such an interaction is
seen in the structure of the Rac1-PLCb2 complex (Protein Data
Bank [PDB] entry 2FJU) (Jezyk et al., 2006), wherein the last
two residues of the acidic stretch form salt bridges with
conserved lysine and arginine side chains on the TIM barrel (Fig-
ure 5). Interestingly, the Ta5 helix, which interacts with Ha20 in the
basal state, contains two of these conserved lysine residues.
Deletion of the acidic stretch breaks this clasp, leading to disor-
dering of the lid helix, as suggested by the crystal structure of
Gaq–PLCb3-D892Dacid (Figure 4B), which lacks electron density
for the lid helix. During catalysis, the clasp could be displaced by
electrostatic repulsion between the acidic stretch and the nega-
tively charged surface of the membrane or by competition be-
tween the acidic stretch and the membrane for the basic patch
on the catalytic core.
A complete picture of the regulation of PLCb activity will only be
obtained after consideration of the contributions made by the
distal CTD, the key membrane-binding determinant. How the
distal CTD influences the roles various regions of the X-Y linker
is currently unknown. There is strong evidence from cryoelectron
microscopy that the PLCb3 distal CTD interacts transiently with
the catalytic core in solution, which could alter membrane parti-
tioning, further occlude the active site, or even interact with the
linker via its own conserved basic region (Lyon et al., 2013). A bet-
ter molecular understanding of how Gbg binds to and activates
PLCb is also essential and will be the subject of future studies.Structure 22, 1844–18EXPERIMENTAL PROCEDURES
Protein Expression, Purification, and Mutagenesis
N-terminally His-tagged human PLCb3 C-terminal truncations comprising
residues 10–847 (PLCb3-D847) and 10–892 (PLCb3-D892), and X-Y linker
deletion variants were expressed in baculovirus-infected High Five cells and
purified as described previously (Lyon et al., 2013). Internal deletions were
introduced via the QuikChange Site-Directed Mutagenesis Kit (Stratagene)
and sequenced over the open reading frame. Efforts to express and purify
PLCb3-D847Dacid were unsuccessful despite several independent attempts
at production and amplification of viruses in Sf9 or High Five cell lines, expres-
sion trials in both of these lines, and variation of time and temperature. There-
fore, we concluded this variant is toxic, which is consistent with the hypothesis
that this should have been the most active variant based on the trends of the
PLCb3-D892 variants (Table 1). Mouse Gaq (residues 7–359) was expressed
and purified as previously described (Lyon et al., 2013).
Bovine Gb1 and N-terminally His-tagged Gg2 baculoviruses were coinfected
into High Five cells and harvested after 40–48 hr. Cells were resuspended in
Buffer A (20 mM HEPES, pH 8, 100 mM NaCl, 10 mM b-mercaptoethanol,
0.1 mM EDTA, 0.1 mM leupeptin, and 0.1 mM phenylmethylsulfonyl fluoride
[PMSF]) and lysed by dounce on ice. The lysatewas centrifuged, and themem-
brane pellets were homogenized by dounce in Buffer A with 1% (w/v) sodium
cholate and stirred at 4C for 1 hr to solubilize the proteins. The slurry was
centrifuged again, and the supernatant was filtered, diluted 2-fold with Buffer
A, and applied to a Ni-NTA Spin Column (QIAGEN) equilibrated with Buffer A.
The column was washed with ten column volumes of Buffer A with 10 mM
imidazole, pH 8.0, and 0.2%cholate, followed by ten column volumes of Buffer
A with 10 mM imidazole, pH 8.0, and 10 mM CHAPS. Gb1g2 was eluted with
Buffer A with 250 mM imidazole, pH 8.0, and 10 mM CHAPS. The sample
was diluted 5-fold with Buffer B (20 mM HEPES, pH 8.0, 1 mM MgCl2, 2 mM
dithiothreitol [DTT], and 1 mM CHAPS), and applied to a MonoQ column
pre-equilibrated with Buffer B. Gb1g2 was then eluted with a gradient of
0–500 mM NaCl. Peaks containing Gb1g2 were pooled, concentrated, and
further purified over tandem S200 columns equilibrated with 20 mM HEPES,
pH 8.0, 50 mM NaCl, 1 mM MgCl2, 2 mM DTT, and either 1 mM or 10 mM
CHAPS.
Protease Protection Assays
Clostripain (0.01 U/25 mg PLCb3) and trypsin (0.05 U/25 mg PLCb3) were used
to digest PLCb3-D892 or PLCb3-D847 at room temperature and assessed at
various time points to identify optimal conditions, which was determined to be
2 hr. To estimate themolecular weights of themajor degradation products with
MALDI-TOFmass spectrometry, 50 ml reactions containing 25 mg PLCb3-D892
or PLCb3-D847, at final concentrations of 4.96 mM and 5.23 mM, respectively,
were digested for 2 hr at room temperature in buffer containing 20mMHEPES,
pH 8, 200 mM NaCl, and 2 mM DTT. Clostripain reactions were quenched by
the addition of 1 mM tosyllysine chloromethylketone, and trypsin reactions by
10 mM PMSF. To map the proteolytic sites, reactions were quenched by the
addition of 43 SDS-PAGE sample buffer, and 10 ml samples were separated
by 10% SDS-PAGE. The bands were excised and analyzed by the Proteomics
Resource at the Fred Hutchinson Cancer Research Center. Peptides were
solubilized and divided into two sets, one of which was subjected to further
proteolysis by thermolysin. All samples (trypsin, clostripain, trypsin and ther-
molysin, and clostripain and thermolysin) were analyzed by MS/MS to deter-
mine the identity of residues within each band. These data were correlated
with the MALDI-TOF data of intact proteolytic fragments (Table S2).
DSF
Tm values for PLCb3 variants were determined as previously described (Lyon
et al., 2011), with the modifications that PLCb3 samples were used at a con-
centration of 0.2 mg/ml and all samples contained 5 mM CaCl2. For assess-
ment of IP3 binding, a final concentration of 5 mM IP3 was added to each
reaction.
PLCb3 Activity Assays
Basal, Gaq-stimulated, and Gb1g2-stimulated PLCb3 activity was quantified
by measuring the amount of free [3H]-IP3 released from [
3H]-PIP2-containing
liposomes. Basal assays and Gaq-stimulated assays were performed as54, December 2, 2014 ª2014 Elsevier Ltd All rights reserved 1851
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Regulation of Phospholipase Cbpreviously described (Ghosh and Smrcka, 2004; Lyon et al., 2011). Gb1g2-
mediated activation assays were carried out similarly, with the addition of
65 mM CHAPS to the reaction. Increasing amounts of Gb1g2 were added to
the PLCb3 variants and incubated for 10–15 min, and reactions were initiated
by the addition of liposomes and transfer to 30C for 5 min. Reactions
were quenched as previously described (Ghosh and Smrcka, 2004; Lyon
et al., 2011). PLCb3-D892, PLCb3-D892DLINPI, and PLCb3-D847Ddisorder
were assayed at 10 ng/ml; PLCb3-D892Ddisorder was assayed at 12 or 18 ng/
ml; PLCb3-D892Dacid and PLCb3-D892Dall were assayed at 0.5 ng/ml;
PLCb3-D847 was assayed at 4 ng/ml; and PLCb3-D847Dall was assayed at
0.1 ng/ml.
Crystallization and Structure Determination of Gaq–PLCb3-892
Variant Complexes
Gaq was preactivated, and Gaq–PLCb3-D892Dacid and Gaq–PLCb3-D892Dall
complexes were formed, purified, and concentrated as previously described
(Lyon et al., 2013). For Gaq–PLCb3-D892Dacid, hanging drops contained
0.7 ml Gaq–PLCb3-D892Dacid at 5.2 mg/ml and 0.7 ml well solution containing
100 mM BisTris, pH 6.0, 200 mM NaCl, and 5% (w/v) polyethylene glycol
(PEG) 3350. Crystals were harvested in 20 mM HEPES, pH 8.0, 400 mM
NaCl, 2 mM DTT, 0.9 mM CaCl2, 5 mM MgCl2, 10 mM NaF, 30 mM AlCl3,
50 mM GDP, 100 mM BisTris, pH 6.0, 10% (w/v) PEG 3350, and 30% (v/v)
1,3-butanediol. For cocrystallization with IP3, Gaq–PLCb3-D892Dacid and
Gaq–PLCb3-D892Dall were incubated 30 min on ice with 5 mM IP3 (Cayman
Chemical). For Gaq–PLCb3-D892Dacid$IP3, hanging drops contained 0.7 ml
protein complex and 0.7 ml well solution containing 100 mM BisTris, pH 6.5,
200 mM NaCl, and 8% (w/v) PEG 3350. Crystals were harvested in 20 mM
HEPES, pH 8.0, 400 mM NaCl, 2 mM DTT, 0.9 mM CaCl2, 5 mM MgCl2,
10 mM NaF, 30 mM AlCl3, 50 mM GDP, 100 mM BisTris, pH 6.5, 10 mM IP3,
10% (w/v) PEG 3350, and 30% (v/v) 1.3-butanediol. For Gaq–PLCb3-
D892Dall$IP3, hanging drops contained 0.7 ml protein complex at 8.8 mg/ml
mixed with 0.7 ml well solution containing 100 mM MES, pH 6.25, 200 mM
NaCl, and 5% (w/v) PEG 3350. Crystals were harvested in 20 mM HEPES,
pH 8.0, 400 mM NaCl, 2 mM DTT, 0.9 mM CaCl2, 5 mM MgCl2, 10 mM NaF,
30 mM AlCl3, 50 mM GDP, 100 mM MES, pH 6.0, 10 mM IP3, 7% (w/v) PEG
3350, and 30% (v/v) glycerol. All crystals were frozen on nylon loops in liquid
N2 for data collection.
Diffraction data were collected at the Advanced Photon Source at Life Sci-
ences Collaborative Access Team (LS-CAT) beamlines 21-ID-F and 21-ID-D
at wavelengths of 0.9787 A˚ and 0.9792 A˚, respectively, from single crystals
maintained at 110 K. Data sets were processed using HKL2000 (Otwinowski
and Minor, 1997), and phases were determined by molecular replacement
using the PDB entry 3OHM structure as a search model (Waldo et al.,
2010). Models were refined in REFMAC (Winn et al., 2003), using two trans-
lation-libration-screw-rotation groups: one for Gaq, GDP, Mg
2+, and AlF4

molecules and one for PLCb3, Ca2+, and IP3, if present. Stereochemical cor-
rectness of the structures was assessed using MolProbity (Davis et al.,
2007). In the final Gaq–PLCb3-D892Dacid structure, 95.9% of residues were
in the favored region of the Ramachandran plot, 3.9% were in allowed re-
gions, and 0.3% were in disallowed regions. Density was observed for Gaq
residues 37–352 and PLCb3-D892Dacid residues 12–91, 96–470, and 582–
882. In the final Gaq–PLCb3-D892Dacid$IP3 structure, 94.2% of residues
were in the favored region of the Ramachandran plot, 4.5% were in allowed
regions, and 1.3% were in disallowed regions. Density was observed for Gaq
residues 35–352 and PLCb3-D892Dacid residues 12–91, 96–470, and 589–
882. In the final Gaq–PLCb3-D892Dall$IP3 structure, 91.2% of residues were
in the favored region of the Ramachandran plot, 6.9% were in the allowed
regions, and 1.9% were in disallowed regions. Density was observed for
Gaq residues 36–352 and PLCb3-D892Dall residues 12–91, 97–470, and
589–881.
Statistical Methods
All statistical analyses used ANOVA with Tukey’s posttest as implemented in
Prism (version 6.0).
Figures
Structural images were generated using PymolX11Hybrid (http://www.pymol.
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